1. Home
  2. WKEY vs IMUX Comparison

WKEY vs IMUX Comparison

Compare WKEY & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WISeKey International Holding Ltd

WKEY

WISeKey International Holding Ltd

HOLD

Current Price

$7.26

Market Cap

83.5M

Sector

Technology

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$1.18

Market Cap

75.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKEY
IMUX
Founded
1999
2016
Country
Switzerland
United States
Employees
102
66
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.5M
75.2M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
WKEY
IMUX
Price
$7.26
$1.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$10.50
$4.25
AVG Volume (30 Days)
64.8K
3.2M
Earning Date
01-01-0001
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$31.22
N/A
Revenue Next Year
$91.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$0.51
52 Week High
$19.80
$1.51

Technical Indicators

Market Signals
Indicator
WKEY
IMUX
Relative Strength Index (RSI) 47.29 57.64
Support Level $6.24 $0.64
Resistance Level $7.52 N/A
Average True Range (ATR) 0.43 0.13
MACD 0.03 0.00
Stochastic Oscillator 37.43 46.99

Price Performance

Historical Comparison
WKEY
IMUX

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: